Photo taken from Patrick Hwu/X
Dec 15, 2023, 06:14
Patrick Hwu: How can we identify tumour-reactive T-cells circulating in the blood?
Patrick Hwu, President and CEO of the Moffitt Cancer Center, shared on X/Twitter:
“Science Saturday. How can we identify tumour-reactive T-cells circulating in the blood? Using single-cell transcriptomic profiling of tumour-infiltrating lymphocytes (TIL) and blood lymphocytes, researchers at the National Cancer Institute’s Surgery branch identified a phenotypic signature of circulating T-cells capable of recognizing mutated antigens.
Interestingly, these circulating T-cells appear to be more functional than those found in the tumour. This approach may provide an important alternative source of T-cells for immunotherapy for cancer. Here’s a link to the full article.”
Source: Patrick Hwu/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 19, 2024, 15:20
Nov 19, 2024, 15:17
Nov 19, 2024, 15:14
Nov 19, 2024, 15:12
Nov 19, 2024, 14:54
Nov 19, 2024, 14:42
Nov 19, 2024, 14:20